These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 5705176)

  • 21. Inhibition of norepinephrine biosynthesis by chlorpromazine in the guinea-pig vas deferens.
    Johnson DG; Thoa NB; Kopin IJ
    J Pharmacol Exp Ther; 1971 Apr; 177(1):146-54. PubMed ID: 4935855
    [No Abstract]   [Full Text] [Related]  

  • 22. Short- and long-term regulation of tyrosine hydroxylase.
    Costa E; Guidotti A; Zivkovic B
    Adv Biochem Psychopharmacol; 1974; 12(0):161-75. PubMed ID: 4154019
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of L-DOPA on S-adenosylmethionine levels and norepinephrine metabolism in rat brain.
    Wurtman RJ
    Adv Biochem Psychopharmacol; 1972; 6():241-6. PubMed ID: 5055596
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of isolated perfused rat brains in a study of 14C-L-DOPA metabolism.
    Horst WD; Jester J
    Life Sci I; 1971 Jun; 10(12):685-9. PubMed ID: 5104924
    [No Abstract]   [Full Text] [Related]  

  • 25. Further studies on catecholamine synthesis in the spontaneously hypertensive rat: catecholamine synthesis in the central nervous system.
    Yamabe H; De Jong W; Lovenberg W
    Eur J Pharmacol; 1973 Apr; 22(1):91-8. PubMed ID: 4145256
    [No Abstract]   [Full Text] [Related]  

  • 26. Thyroxine and brain catecholamines: increased transmitter synthesis and increased receptor sensitivity.
    Engström G; Svensson TH; Waldeck B
    Brain Res; 1974 Sep; 77(3):471-83. PubMed ID: 4855210
    [No Abstract]   [Full Text] [Related]  

  • 27. Drugs affecting monoamines in the basal ganglia.
    Bartholini G; Pletscher A
    Adv Biochem Psychopharmacol; 1972; 6():135-48. PubMed ID: 4560163
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of single and repeated administration of clozapine on the metabolism of dopamine and noradrenaline in the brain of the rat.
    Bürki HR; Ruch W; Asper H; Baggiolini M; Stille G
    Eur J Pharmacol; 1974 Jul; 27(2):180-90. PubMed ID: 4152854
    [No Abstract]   [Full Text] [Related]  

  • 29. Biochemical pharmacology of catecholamines and its clinical implications.
    Axelrod J
    Trans Am Neurol Assoc; 1971; 96():179-86. PubMed ID: 4400652
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanism of the gamma-hydroxybutyrate-induced increase in brain dopamine and its relationship to "sleep".
    Roth RH; Suhr Y
    Biochem Pharmacol; 1970 Dec; 19(12):3001-12. PubMed ID: 5513037
    [No Abstract]   [Full Text] [Related]  

  • 31. Catecholamine metabolism in neonatal rat brain during asphyxia and recovery.
    Hedner T; Lundborg P
    Acta Physiol Scand; 1980 Jun; 109(2):169-75. PubMed ID: 6775492
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of apomorphine and pimozide on synthesis and turnover of labelled catecholamines in mouse brain.
    Nybäck H; Schubert J; Sedvall G
    J Pharm Pharmacol; 1970 Aug; 22(8):622-4. PubMed ID: 4394540
    [No Abstract]   [Full Text] [Related]  

  • 33. In vivo release of endogenously synthesized catecholamines from the cat brain evoked by electrical stimulation and by d-amphetamine.
    Chiueh CC; Moore KE
    J Neurochem; 1974 Jul; 23(1):159-68. PubMed ID: 4852387
    [No Abstract]   [Full Text] [Related]  

  • 34. Alteration of rat brain catecholamine metabolism during exposure to hypobaric hypoxia.
    Cymerman A; Robinson SM; McCullough D
    Can J Physiol Pharmacol; 1972 Apr; 50(4):321-7. PubMed ID: 4402610
    [No Abstract]   [Full Text] [Related]  

  • 35. Biochemical and pharmacological aspects of Parkinsonism.
    Carlsson A
    Acta Neurol Scand Suppl; 1972; 51():11-42. PubMed ID: 4351191
    [No Abstract]   [Full Text] [Related]  

  • 36. The influence of norepinephrine on the distribution of radioactivity from some of its 14C-labeled analogues and precursors.
    Gordon MW; Deanin GG; Hanson RK
    Biochem Pharmacol; 1967 May; 16(5):793-802. PubMed ID: 6036731
    [No Abstract]   [Full Text] [Related]  

  • 37. L-dopa in Parkinsonism. A possible mechanism of action.
    Ng LK; Chase TN; Colburn RW; Kopin IJ
    Neurology; 1972 Jul; 22(7):688-96. PubMed ID: 4673250
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of neuroleptics on the disappearance rate of (14C) labelled catecholamines formed from (14C)tyrosine in mouse brain.
    Hyttel J
    J Pharm Pharmacol; 1974 Aug; 26(8):588-96. PubMed ID: 4155723
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of social stress on the turnover of brain catecholamines and 5-hydroxytryptamine in mice.
    Modigh K
    Acta Pharmacol Toxicol (Copenh); 1974 Feb; 34(2):97-105. PubMed ID: 4545032
    [No Abstract]   [Full Text] [Related]  

  • 40. The influence of chlorpromazine on the uptake of biogenic amines by rat mast cells in vitro.
    Frisk-Holmberg M; Uvnäs B
    Acta Physiol Scand; 1972 Sep; 86(1):1-11. PubMed ID: 4674070
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.